Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease.

Riddell LA, Pinching AJ, Hill S, Ng TT, Arbe E, Lapham GP, Ash S, Hillman R, Tchamouroff S, Denning DW, Parkin JM.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):789-97.

PMID:
11429120
2.

Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

Pappas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, Aberg J, Hasbun R, Hsu HH.

J Infect Dis. 2004 Jun 15;189(12):2185-91. Epub 2004 May 24.

PMID:
15181565
3.

Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.

Angel JB, High K, Rhame F, Brand D, Whitmore JB, Agosti JM, Gilbert MJ, Deresinski S.

AIDS. 2000 Mar 10;14(4):387-95.

PMID:
10770541
4.

Recombinant interferon gamma therapy for atopic dermatitis.

Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, Bucalo LR, Hirabayashi SE, Tofte SJ, Cantu-Gonzales G, et al.

J Am Acad Dermatol. 1993 Feb;28(2 Pt 1):189-97.

PMID:
8432915
5.

Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.

Bemiller LS, Roberts DH, Starko KM, Curnutte JT.

Blood Cells Mol Dis. 1995;21(3):239-47.

PMID:
8673477
6.

Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma.

Jang IG, Yang JK, Lee HJ, Yi JY, Kim HO, Kim CW, Kim TY.

J Am Acad Dermatol. 2000 Jun;42(6):1033-40.

PMID:
10827410
7.

A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients.

Polk HC Jr, Cheadle WG, Livingston DH, Rodriguez JL, Starko KM, Izu AE, Jaffe HS, Sonnenfeld G.

Am J Surg. 1992 Feb;163(2):191-6.

PMID:
1739172
8.

Prospective 5-year followup of recombinant interferon-gamma in rheumatoid arthritis.

Cannon GW, Emkey RD, Denes A, Cohen SA, Saway PA, Wolfe F, Jaffer AM, Weaver AL, Manaster BJ, McCarthy KA.

J Rheumatol. 1993 Nov;20(11):1867-73.

PMID:
8308771
9.
10.

Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.

Quesada JR, Evans L, Saks SR, Gutterman JU.

J Biol Response Mod. 1988 Jun;7(3):234-9.

PMID:
3134511
11.

Recombinant interferon-gamma (rIFN-gamma) in dermatology.

Mahrle G, Schulze HJ.

J Invest Dermatol. 1990 Dec;95(6 Suppl):132S-137S.

PMID:
2124242
12.
13.

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA.

Ann Intern Med. 2000 Oct 3;133(7):493-503.

PMID:
11015162
14.

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.

Cancer. 2006 Jun 15;106(12):2664-71.

15.

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM, et al.

AIDS. 1994 Mar;8(3):313-21. Erratum in: AIDS 1994 Jun;8(6):following 859.

PMID:
7913326
16.

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.

Clin Cancer Res. 2000 Jun;6(6):2268-78.

17.

Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.

Schiller JH, Storer B, Bittner G, Willson JK, Borden EC.

J Interferon Res. 1988 Oct;8(5):581-9.

PMID:
3148669
18.

Clinical study with recombinant interferon gamma versus interferon alpha-2c in patients with condylomata acuminata.

Reichel RP, Fitz R, Neumann R, Pohl-Markl H, Pichler E, Hoffer Z, Budiman R.

Int J STD AIDS. 1992 Sep-Oct;3(5):350-4.

PMID:
1391062
20.

A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, et al.

N Engl J Med. 1995 Aug 17;333(7):408-13. Erratum in: N Engl J Med 1995 Nov 16;333(20):1367.

Supplemental Content

Support Center